A phase I/II clinical trial of Carbon-ion therapy in 12 fractions over 3 weeks for patients with carcinoma of kidney
Phase 1
- Conditions
- Renal Cancer
- Registration Number
- JPRN-UMIN000008777
- Lead Sponsor
- ational Institute of Radiological Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)Past history of radiotherapy to the corresponding site. 2)Prior administration of the molecular targeting drugs. 3)Difficult to reduce the dose to the bowels to lower than 60% of the prescribed dose. 4)Tumor exceeding 15cm in maximum diameter. 5)Atypical renal cancer such as Bellini duct carcinoma 6)Carcinome developed in dialyzed kidney 7)Active other malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute radiation toxicity of normal tissue
- Secondary Outcome Measures
Name Time Method ate radiation toxicity of normal tissue Local control rate Survival rate